25 XP   0   0   10

Yabao Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Yabao together

PenkeI guess you are interested in Yabao Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Yabao Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Yabao Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Yabao Pharmaceutical Group Co Ltd.

Quick analysis of Yabao (30 sec.)










What can you expect buying and holding a share of Yabao? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.90
Expected worth in 1 year
¥4.13
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.65
Return On Investment
10.6%

For what price can you sell your share?

Current Price per Share
¥6.12
Expected price per share
¥4.94 - ¥6.55
How sure are you?
50%

1. Valuation of Yabao (5 min.)




Live pricePrice per Share (EOD)

¥6.12

Intrinsic Value Per Share

¥3.82 - ¥7.84

Total Value Per Share

¥7.72 - ¥11.74

2. Growth of Yabao (5 min.)




Is Yabao growing?

Current yearPrevious yearGrowGrow %
How rich?$415.5m$409.5m$5.9m1.4%

How much money is Yabao making?

Current yearPrevious yearGrowGrow %
Making money$14.4m$25.8m-$11.3m-78.8%
Net Profit Margin3.9%6.8%--

How much money comes from the company's main activities?

3. Financial Health of Yabao (5 min.)




What can you expect buying and holding a share of Yabao? (5 min.)

Welcome investor! Yabao's management wants to use your money to grow the business. In return you get a share of Yabao.

What can you expect buying and holding a share of Yabao?

First you should know what it really means to hold a share of Yabao. And how you can make/lose money.

Speculation

The Price per Share of Yabao is ¥6.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Yabao.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Yabao, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.90. Based on the TTM, the Book Value Change Per Share is ¥0.06 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Yabao.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.3%0.020.3%0.030.5%0.020.4%0.030.4%
Usd Book Value Change Per Share0.010.1%0.010.1%0.030.4%0.010.1%0.020.4%
Usd Dividend Per Share0.010.2%0.010.2%0.010.2%0.020.3%0.020.3%
Usd Total Gains Per Share0.020.4%0.020.4%0.040.6%0.030.4%0.040.7%
Usd Price Per Share0.81-0.81-1.25-0.87-1.10-
Price to Earnings Ratio43.26-43.26-37.37-91.07-95.66-
Price-to-Total Gains Ratio36.32-36.32-34.00-74.46-52.22-
Price to Book Ratio1.51-1.51-2.36-1.67-2.42-
Price-to-Total Gains Ratio36.32-36.32-34.00-74.46-52.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.845784
Number of shares1182
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.02
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.020.03
Gains per Quarter (1182 shares)26.4529.63
Gains per Year (1182 shares)105.79118.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16937969226109
21397320218453228
320811030827679347
4277146414369105466
5346183520461132585
6416219626553158704
7485256732645185823
8554292838737211942
96233299448292371061
1069336510509222641180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%21.02.00.091.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.01.095.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%

Fundamentals of Yabao

About Yabao Pharmaceutical Group Co Ltd

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. The company provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.

Fundamental data was last updated by Penke on 2024-04-17 06:58:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Yabao Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Yabao earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Yabao to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 3.9% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Yabao Pharmaceutical Group Co Ltd:

  • The MRQ is 3.9%. The company is making a profit. +1
  • The TTM is 3.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.9%TTM3.9%0.0%
TTM3.9%YOY6.8%-2.9%
TTM3.9%5Y4.9%-1.1%
5Y4.9%10Y6.1%-1.2%
1.1.2. Return on Assets

Shows how efficient Yabao is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Yabao to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.5% Return on Assets means that Yabao generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Yabao Pharmaceutical Group Co Ltd:

  • The MRQ is 2.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.5%TTM2.5%0.0%
TTM2.5%YOY4.6%-2.1%
TTM2.5%5Y3.2%-0.6%
5Y3.2%10Y3.5%-0.4%
1.1.3. Return on Equity

Shows how efficient Yabao is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Yabao to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.5% Return on Equity means Yabao generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Yabao Pharmaceutical Group Co Ltd:

  • The MRQ is 3.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.5%TTM3.5%0.0%
TTM3.5%YOY6.4%-2.9%
TTM3.5%5Y4.7%-1.2%
5Y4.7%10Y5.6%-0.9%

1.2. Operating Efficiency of Yabao Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Yabao is operating .

  • Measures how much profit Yabao makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Yabao to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 6.6% means the company generated ¥0.07  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Yabao Pharmaceutical Group Co Ltd:

  • The MRQ is 6.6%. The company is operating less efficient.
  • The TTM is 6.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.6%TTM6.6%0.0%
TTM6.6%YOY8.1%-1.6%
TTM6.6%5Y8.5%-1.9%
5Y8.5%10Y7.7%+0.7%
1.2.2. Operating Ratio

Measures how efficient Yabao is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.36 means that the operating costs are ¥1.36 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Yabao Pharmaceutical Group Co Ltd:

  • The MRQ is 1.362. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.362. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.362TTM1.3620.000
TTM1.362YOY1.309+0.054
TTM1.3625Y1.304+0.058
5Y1.30410Y1.168+0.136

1.3. Liquidity of Yabao Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Yabao is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.88 means the company has ¥1.88 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Yabao Pharmaceutical Group Co Ltd:

  • The MRQ is 1.878. The company is able to pay all its short-term debts. +1
  • The TTM is 1.878. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.878TTM1.8780.000
TTM1.878YOY1.787+0.091
TTM1.8785Y1.605+0.273
5Y1.60510Y1.203+0.402
1.3.2. Quick Ratio

Measures if Yabao is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Yabao to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.42 means the company can pay off ¥0.42 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Yabao Pharmaceutical Group Co Ltd:

  • The MRQ is 0.417. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.417. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.417TTM0.4170.000
TTM0.417YOY0.422-0.005
TTM0.4175Y0.500-0.084
5Y0.50010Y0.465+0.036

1.4. Solvency of Yabao Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Yabao assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Yabao to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.27 means that Yabao assets are financed with 27.2% credit (debt) and the remaining percentage (100% - 27.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Yabao Pharmaceutical Group Co Ltd:

  • The MRQ is 0.272. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.272. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.272TTM0.2720.000
TTM0.272YOY0.273-0.001
TTM0.2725Y0.317-0.045
5Y0.31710Y0.354-0.037
1.4.2. Debt to Equity Ratio

Measures if Yabao is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Yabao to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 37.9% means that company has ¥0.38 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Yabao Pharmaceutical Group Co Ltd:

  • The MRQ is 0.379. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.379. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.379TTM0.3790.000
TTM0.379YOY0.380-0.002
TTM0.3795Y0.481-0.103
5Y0.48110Y0.572-0.091

2. Market Valuation of Yabao Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Yabao generates.

  • Above 15 is considered overpriced but always compare Yabao to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 43.26 means the investor is paying ¥43.26 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Yabao Pharmaceutical Group Co Ltd:

  • The EOD is 45.028. Based on the earnings, the company is overpriced. -1
  • The MRQ is 43.262. Based on the earnings, the company is overpriced. -1
  • The TTM is 43.262. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD45.028MRQ43.262+1.766
MRQ43.262TTM43.2620.000
TTM43.262YOY37.370+5.892
TTM43.2625Y91.071-47.809
5Y91.07110Y95.663-4.592
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Yabao Pharmaceutical Group Co Ltd:

  • The EOD is 11.833. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 11.369. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 11.369. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD11.833MRQ11.369+0.464
MRQ11.369TTM11.3690.000
TTM11.369YOY20.416-9.047
TTM11.3695Y14.589-3.219
5Y14.58910Y185.148-170.560
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Yabao is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Yabao Pharmaceutical Group Co Ltd:

  • The EOD is 1.567. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.506. Based on the equity, the company is underpriced. +1
  • The TTM is 1.506. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.567MRQ1.506+0.061
MRQ1.506TTM1.5060.000
TTM1.506YOY2.359-0.853
TTM1.5065Y1.669-0.163
5Y1.66910Y2.415-0.746
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Yabao Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0560.0560%0.189-70%0.040+39%0.181-69%
Book Value Per Share--3.9053.9050%3.849+1%3.756+4%3.407+15%
Current Ratio--1.8781.8780%1.787+5%1.605+17%1.203+56%
Debt To Asset Ratio--0.2720.2720%0.2730%0.317-14%0.354-23%
Debt To Equity Ratio--0.3790.3790%0.3800%0.481-21%0.572-34%
Dividend Per Share--0.1060.1060%0.078+35%0.141-25%0.138-23%
Eps--0.1360.1360%0.243-44%0.177-23%0.183-26%
Free Cash Flow Per Share--0.5170.5170%0.445+16%0.436+19%0.236+119%
Free Cash Flow To Equity Per Share--0.5170.5170%0.202+156%0.168+208%0.180+187%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--7.837--------
Intrinsic Value_10Y_min--3.817--------
Intrinsic Value_1Y_max--0.530--------
Intrinsic Value_1Y_min--0.275--------
Intrinsic Value_3Y_max--1.787--------
Intrinsic Value_3Y_min--0.925--------
Intrinsic Value_5Y_max--3.279--------
Intrinsic Value_5Y_min--1.677--------
Market Cap4712400000.000+4%4527600135.2404527600135.2400%6991600208.840-35%4854788803.628-7%6127569165.876-26%
Net Profit Margin--0.0390.0390%0.068-43%0.049-22%0.061-37%
Operating Margin--0.0660.0660%0.081-19%0.085-23%0.077-15%
Operating Ratio--1.3621.3620%1.309+4%1.304+4%1.168+17%
Pb Ratio1.567+4%1.5061.5060%2.359-36%1.669-10%2.415-38%
Pe Ratio45.028+4%43.26243.2620%37.370+16%91.071-52%95.663-55%
Price Per Share6.120+4%5.8805.8800%9.080-35%6.280-6%7.929-26%
Price To Free Cash Flow Ratio11.833+4%11.36911.3690%20.416-44%14.589-22%185.148-94%
Price To Total Gains Ratio37.799+4%36.31736.3170%34.001+7%74.465-51%52.221-30%
Quick Ratio--0.4170.4170%0.422-1%0.500-17%0.465-10%
Return On Assets--0.0250.0250%0.046-45%0.032-20%0.035-28%
Return On Equity--0.0350.0350%0.064-45%0.047-26%0.056-38%
Total Gains Per Share--0.1620.1620%0.267-39%0.181-11%0.318-49%
Usd Book Value--415517931.303415517931.3030%409566913.903+1%401492020.432+3%364359698.848+14%
Usd Book Value Change Per Share--0.0080.0080%0.026-70%0.006+39%0.025-69%
Usd Book Value Per Share--0.5400.5400%0.532+1%0.519+4%0.471+15%
Usd Dividend Per Share--0.0150.0150%0.011+35%0.019-25%0.019-23%
Usd Eps--0.0190.0190%0.034-44%0.024-23%0.025-26%
Usd Free Cash Flow--55035500.56655035500.5660%47326706.953+16%46585709.614+18%25203304.576+118%
Usd Free Cash Flow Per Share--0.0710.0710%0.061+16%0.060+19%0.033+119%
Usd Free Cash Flow To Equity Per Share--0.0710.0710%0.028+156%0.023+208%0.025+187%
Usd Market Cap651253680.000+4%625714338.690625714338.6900%966239148.862-35%670931812.661-7%846830058.724-26%
Usd Price Per Share0.846+4%0.8130.8130%1.255-35%0.868-6%1.096-26%
Usd Profit--14463331.14214463331.1420%25855758.377-44%18970873.209-24%19617385.167-26%
Usd Revenue--375646227.359375646227.3590%381979614.954-2%388190960.990-3%331436040.442+13%
Usd Total Gains Per Share--0.0220.0220%0.037-39%0.025-11%0.044-49%
 EOD+4 -4MRQTTM+0 -0YOY+17 -185Y+17 -1810Y+16 -19

3.2. Fundamental Score

Let's check the fundamental score of Yabao Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1545.028
Price to Book Ratio (EOD)Between0-11.567
Net Profit Margin (MRQ)Greater than00.039
Operating Margin (MRQ)Greater than00.066
Quick Ratio (MRQ)Greater than10.417
Current Ratio (MRQ)Greater than11.878
Debt to Asset Ratio (MRQ)Less than10.272
Debt to Equity Ratio (MRQ)Less than10.379
Return on Equity (MRQ)Greater than0.150.035
Return on Assets (MRQ)Greater than0.050.025
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Yabao Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.600
Ma 20Greater thanMa 506.225
Ma 50Greater thanMa 1006.148
Ma 100Greater thanMa 2006.599
OpenGreater thanClose6.080
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,131,067
Total Liabilities1,124,425
Total Stockholder Equity2,970,077
 As reported
Total Liabilities 1,124,425
Total Stockholder Equity+ 2,970,077
Total Assets = 4,131,067

Assets

Total Assets4,131,067
Total Current Assets1,954,334
Long-term Assets2,176,733
Total Current Assets
Cash And Cash Equivalents 668,503
Net Receivables 433,680
Inventory 449,136
Other Current Assets 49,897
Total Current Assets  (as reported)1,954,334
Total Current Assets  (calculated)1,601,217
+/- 353,117
Long-term Assets
Property Plant Equipment 1,376,834
Goodwill 26,268
Intangible Assets 334,342
Other Assets 271,605
Long-term Assets  (as reported)2,176,733
Long-term Assets  (calculated)2,009,049
+/- 167,684

Liabilities & Shareholders' Equity

Total Current Liabilities1,040,668
Long-term Liabilities83,757
Total Stockholder Equity2,970,077
Total Current Liabilities
Short Long Term Debt 410,262
Accounts payable 166,938
Other Current Liabilities 308,490
Total Current Liabilities  (as reported)1,040,668
Total Current Liabilities  (calculated)885,690
+/- 154,978
Long-term Liabilities
Long term Debt 2,000
Capital Lease Obligations Min Short Term Debt5,103
Long-term Liabilities  (as reported)83,757
Long-term Liabilities  (calculated)7,103
+/- 76,655
Total Stockholder Equity
Retained Earnings 1,022,259
Total Stockholder Equity (as reported)2,970,077
Total Stockholder Equity (calculated)1,022,259
+/- 1,947,819
Other
Capital Stock770,000
Common Stock Shares Outstanding 770,000
Net Invested Capital 3,382,340
Net Tangible Assets 2,788,212
Net Working Capital 913,666
Property Plant and Equipment Gross 1,376,834



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
221,065
261,427
447,376
664,931
937,811
1,134,788
1,010,275
1,074,311
1,674,249
2,210,404
2,431,204
2,270,350
2,884,378
3,202,335
3,184,998
4,251,824
4,205,513
4,368,578
4,826,248
4,312,638
4,014,287
4,076,677
4,131,067
4,131,0674,076,6774,014,2874,312,6384,826,2484,368,5784,205,5134,251,8243,184,9983,202,3352,884,3782,270,3502,431,2042,210,4041,674,2491,074,3111,010,2751,134,788937,811664,931447,376261,427221,065
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,032,118
1,589,954
1,798,097
2,347,285
2,069,923
1,725,030
1,797,084
1,954,334
1,954,3341,797,0841,725,0302,069,9232,347,2851,798,0971,589,9542,032,118000000000000000
       Cash And Cash Equivalents 
10,268
30,671
170,308
192,011
145,316
183,959
41,262
69,307
401,759
609,539
392,684
219,281
510,502
577,700
209,002
1,015,028
503,325
408,296
788,978
484,720
350,412
477,049
668,503
668,503477,049350,412484,720788,978408,296503,3251,015,028209,002577,700510,502219,281392,684609,539401,75969,30741,262183,959145,316192,011170,30830,67110,268
       Short-term Investments 
0
0
0
200
2,091
2,043
0
0
736
0
0
0
1,695
12,691
785
0
5,763
0
16,693
0
100
0
0
00100016,69305,763078512,6911,695000736002,0432,091200000
       Net Receivables 
60,073
73,769
104,059
141,616
147,947
185,311
180,351
195,879
162,865
189,418
293,709
365,455
337,440
386,498
447,024
561,543
531,940
843,787
953,143
978,861
468,930
424,053
433,680
433,680424,053468,930978,861953,143843,787531,940561,543447,024386,498337,440365,455293,709189,418162,865195,879180,351185,311147,947141,616104,05973,76960,073
       Other Current Assets 
15,306
10,014
4,353
12,090
19,517
17,019
15,136
19,458
46,357
56,055
50,175
31,318
52,519
77,681
62,279
76,856
67,166
37,374
31,625
44,681
72,293
54,943
49,897
49,89754,94372,29344,68131,62537,37467,16676,85662,27977,68152,51931,31850,17556,05546,35719,45815,13617,01919,51712,0904,35310,01415,306
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,615,559
2,570,481
2,478,963
2,242,715
2,289,257
2,279,593
2,176,733
2,176,7332,279,5932,289,2572,242,7152,478,9632,570,4812,615,5590000000000000000
       Property Plant Equipment 
81,151
94,568
114,444
204,231
441,237
669,850
624,139
619,077
561,977
958,860
1,179,339
1,333,350
1,579,816
1,766,772
1,861,651
1,876,104
1,925,621
1,833,571
1,741,065
1,664,946
1,564,524
1,454,128
1,376,834
1,376,8341,454,1281,564,5241,664,9461,741,0651,833,5711,925,6211,876,1041,861,6511,766,7721,579,8161,333,3501,179,339958,860561,977619,077624,139669,850441,237204,231114,44494,56881,151
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,695
330,762
330,762
330,762
66,995
74,568
74,568
26,268
26,26874,56874,56866,995330,762330,762330,76218,695000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71,050
71,050
95,453
93,889
0
0
0
0
000093,88995,45371,05071,050000000000000000
       Intangible Assets 
0
117
116
2,863
55,687
6,315
3,908
3,230
152,444
3,744
15,173
20,664
20,829
23,162
144,501
148,789
225,682
221,716
222,607
267,000
282,828
303,036
334,342
334,342303,036282,828267,000222,607221,716225,682148,789144,50123,16220,82920,66415,1733,744152,4443,2303,9086,31555,6872,8631161170
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,104
19,928
22,770
44,086
28,146
57,918
14,455
14,45557,91828,14644,08622,77019,92820,1040000000000000000
> Total Liabilities 
135,424
169,585
169,571
346,671
599,649
780,420
675,740
694,232
843,934
1,310,853
1,428,646
1,111,584
1,268,961
1,506,122
1,365,109
1,573,806
1,475,160
1,454,145
1,813,469
1,588,234
1,195,932
1,113,096
1,124,425
1,124,4251,113,0961,195,9321,588,2341,813,4691,454,1451,475,1601,573,8061,365,1091,506,1221,268,9611,111,5841,428,6461,310,853843,934694,232675,740780,420599,649346,671169,571169,585135,424
   > Total Current Liabilities 
41,684
109,285
137,571
285,511
514,747
609,145
480,765
555,522
656,435
938,247
1,014,055
937,420
1,063,935
1,266,170
1,144,462
1,393,328
1,328,518
1,335,783
1,691,718
1,475,000
1,100,003
1,005,405
1,040,668
1,040,6681,005,4051,100,0031,475,0001,691,7181,335,7831,328,5181,393,3281,144,4621,266,1701,063,935937,4201,014,055938,247656,435555,522480,765609,145514,747285,511137,571109,28541,684
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,345
880,000
830,000
1,020,000
0
0
0
0
00001,020,000830,000880,00034,345000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,345
880,000
830,000
1,020,000
899,811
628,319
502,368
410,262
410,262502,368628,319899,8111,020,000830,000880,00034,345000000000000000
       Accounts payable 
8,112
13,036
18,349
37,218
141,249
154,445
87,312
98,032
172,314
173,978
145,480
112,521
99,241
179,957
215,776
212,487
181,441
195,321
275,786
161,318
153,048
120,662
166,938
166,938120,662153,048161,318275,786195,321181,441212,487215,776179,95799,241112,521145,480173,978172,31498,03287,312154,445141,24937,21818,34913,0368,112
       Other Current Liabilities 
25,132
13,939
30,172
20,293
32,498
46,200
73,453
90,490
125,921
443,269
472,575
164,899
149,521
165,790
248,512
214,024
143,521
153,510
241,277
303,199
212,658
265,808
308,490
308,490265,808212,658303,199241,277153,510143,521214,024248,512165,790149,521164,899472,575443,269125,92190,49073,45346,20032,49820,29330,17213,93925,132
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
146,641
118,361
121,751
113,234
95,930
107,691
83,757
83,757107,69195,930113,234121,751118,361146,6410000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-34,345
-880,000
-830,000
-1,020,000
0
10,346
8,517
5,103
5,1038,51710,3460-1,020,000-830,000-880,000-34,345000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,190
20,017
19,844
19,672
0
0
0
00019,67219,84420,01747,1900000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,835
27,175
33,361
45,844
97,486
124,761
146,348
0
0146,348124,76197,48645,84433,36127,17524,835000000000000000
> Total Stockholder Equity
79,616
86,578
271,771
296,925
306,544
328,929
322,707
360,257
798,315
873,284
986,037
1,140,820
1,599,891
1,683,486
1,812,088
2,680,491
2,624,308
2,808,770
2,896,431
2,688,968
2,778,411
2,926,965
2,970,077
2,970,0772,926,9652,778,4112,688,9682,896,4312,808,7702,624,3082,680,4911,812,0881,683,4861,599,8911,140,820986,037873,284798,315360,257322,707328,929306,544296,925271,77186,57879,616
   Common Stock
75,000
75,000
115,000
115,000
172,500
172,500
133,125
133,125
158,238
316,476
632,952
632,952
692,000
692,000
692,000
787,041
787,041
787,041
787,041
770,000
770,000
770,000
0
0770,000770,000770,000787,041787,041787,041787,041692,000692,000692,000632,952632,952316,476158,238133,125133,125172,500172,500115,000115,00075,00075,000
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
119
-17,490
-20,015
-20,051
0
0-20,051-20,015-17,490119100000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,944,892
Cost of Revenue-1,282,411
Gross Profit1,662,4811,662,481
 
Operating Income (+$)
Gross Profit1,662,481
Operating Expense-2,612,470
Operating Income332,422-949,989
 
Operating Expense (+$)
Research Development123,668
Selling General Administrative991,380
Selling And Marketing Expenses-
Operating Expense2,612,4701,115,048
 
Net Interest Income (+$)
Interest Income6,330
Interest Expense-15,416
Other Finance Cost-2,862
Net Interest Income-6,225
 
Pretax Income (+$)
Operating Income332,422
Net Interest Income-6,225
Other Non-Operating Income Expenses-
Income Before Tax (EBT)242,910332,422
EBIT - interestExpense = -15,416
211,623
227,039
Interest Expense15,416
Earnings Before Interest and Taxes (EBIT)-258,326
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax242,910
Tax Provision-33,149
Net Income From Continuing Ops209,761209,761
Net Income211,623
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-6,225
 

Technical Analysis of Yabao
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Yabao. The general trend of Yabao is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Yabao's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Yabao Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.49 < 6.5 < 6.55.

The bearish price targets are: 5.97 > 5.91 > 4.94.

Tweet this
Yabao Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Yabao Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Yabao Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Yabao Pharmaceutical Group Co Ltd. The current macd is -0.02615892.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Yabao price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Yabao. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Yabao price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Yabao Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartYabao Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Yabao Pharmaceutical Group Co Ltd. The current adx is 14.04.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Yabao shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Yabao Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Yabao Pharmaceutical Group Co Ltd. The current sar is 5.97911352.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Yabao Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Yabao Pharmaceutical Group Co Ltd. The current rsi is 45.60. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Yabao Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartYabao Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Yabao Pharmaceutical Group Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Yabao price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Yabao Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartYabao Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Yabao Pharmaceutical Group Co Ltd. The current cci is -64.75370636.

Yabao Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartYabao Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Yabao Pharmaceutical Group Co Ltd. The current cmo is -12.49289567.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Yabao Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartYabao Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Yabao Pharmaceutical Group Co Ltd. The current willr is -74.13793103.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Yabao is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Yabao Pharmaceutical Group Co Ltd Daily Williams %R ChartYabao Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Yabao Pharmaceutical Group Co Ltd.

Yabao Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Yabao Pharmaceutical Group Co Ltd. The current atr is 0.1604928.

Yabao Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartYabao Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Yabao Pharmaceutical Group Co Ltd. The current obv is 762,945,342.

Yabao Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartYabao Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Yabao Pharmaceutical Group Co Ltd. The current mfi is 69.50.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Yabao Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartYabao Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Yabao Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Yabao Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Yabao Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.600
Ma 20Greater thanMa 506.225
Ma 50Greater thanMa 1006.148
Ma 100Greater thanMa 2006.599
OpenGreater thanClose6.080
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Yabao with someone you think should read this too:
  • Are you bullish or bearish on Yabao? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Yabao? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Yabao Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Yabao Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Yabao Pharmaceutical Group Co Ltd.

Receive notifications about Yabao Pharmaceutical Group Co Ltd in your mailbox!